About the Fund

Investment Criteria

Contact Our Team

Paul Nolde

Fund Manager/Managing Director
Investment Committee Chair


If you wish to apply for investment consideration, please complete this brief assessment and email the results and the pitch deck to Paul Nolde (paul@riverflow.vc).

Board Members

Monique Adams*

Executive Director, 757 Angels
Chandra Briggman

Chandra Briggman

CEO, Activation Capital
RGF Board Chair

Jim Cheng*

Investor and Exited Entrepreneur

Dave Levin, M.D.*

Chief Medical and Information Officer, Phlow Corp.

Bob Mooney*

Co-Founder / Managing Director, NRV

*Investment Committee

Portfolio Companies

DrugViu is generating the most comprehensive data for autoimmune research by combining medical records with validated patient-reported outcomes, a proprietary autoimmune biorepository and access to patients for clinical research.

Floreo is leveraging the power of Virtual Reality to provide a method of teaching social, behavioral, communication and life skills for individuals with Autism Spectrum Disorder (ASD) and related diagnoses.